Logo image of CCS

CENTURY COMMUNITIES INC (CCS) Stock Fundamental Analysis

NYSE:CCS - New York Stock Exchange, Inc. - US1565043007 - Common Stock - Currency: USD

61.49  +0.83 (+1.37%)

Fundamental Rating

5

Taking everything into account, CCS scores 5 out of 10 in our fundamental rating. CCS was compared to 63 industry peers in the Household Durables industry. CCS has only an average score on both its financial health and profitability. CCS is valued quite cheap, but it does not seem to be growing. These ratings would make CCS suitable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CCS was profitable.
In the past year CCS had a positive cash flow from operations.
CCS had positive earnings in each of the past 5 years.
CCS had a positive operating cash flow in 4 of the past 5 years.
CCS Yearly Net Income VS EBIT VS OCF VS FCFCCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.68%, CCS is in line with its industry, outperforming 58.73% of the companies in the same industry.
With a Return On Equity value of 10.14%, CCS perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
CCS has a Return On Invested Capital of 7.69%. This is comparable to the rest of the industry: CCS outperforms 55.56% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCS is in line with the industry average of 10.05%.
Industry RankSector Rank
ROA 5.68%
ROE 10.14%
ROIC 7.69%
ROA(3y)9.18%
ROA(5y)9.81%
ROE(3y)16.01%
ROE(5y)18.47%
ROIC(3y)11.48%
ROIC(5y)12.4%
CCS Yearly ROA, ROE, ROICCCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With a Profit Margin value of 6.03%, CCS perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Profit Margin of CCS has grown nicely.
CCS has a Operating Margin (9.89%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CCS has grown nicely.
CCS's Gross Margin of 22.08% is on the low side compared to the rest of the industry. CCS is outperformed by 66.67% of its industry peers.
In the last couple of years the Gross Margin of CCS has grown nicely.
Industry RankSector Rank
OM 9.89%
PM (TTM) 6.03%
GM 22.08%
OM growth 3Y-12.42%
OM growth 5Y9.7%
PM growth 3Y-13.74%
PM growth 5Y11.24%
GM growth 3Y-4.17%
GM growth 5Y4%
CCS Yearly Profit, Operating, Gross MarginsCCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

CCS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CCS has been reduced compared to 1 year ago.
CCS has less shares outstanding than it did 5 years ago.
CCS has a worse debt/assets ratio than last year.
CCS Yearly Shares OutstandingCCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CCS Yearly Total Debt VS Total AssetsCCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.29 indicates that CCS is not in any danger for bankruptcy at the moment.
The Altman-Z score of CCS (3.29) is comparable to the rest of the industry.
CCS has a debt to FCF ratio of 12.10. This is a negative value and a sign of low solvency as CCS would need 12.10 years to pay back of all of its debts.
CCS has a Debt to FCF ratio of 12.10. This is comparable to the rest of the industry: CCS outperforms 52.38% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that CCS is somewhat dependend on debt financing.
CCS has a Debt to Equity ratio of 0.62. This is in the lower half of the industry: CCS underperforms 65.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 12.1
Altman-Z 3.29
ROIC/WACC0.95
WACC8.11%
CCS Yearly LT Debt VS Equity VS FCFCCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CCS has a Current Ratio of 8.56. This indicates that CCS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.56, CCS belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
A Quick Ratio of 0.38 indicates that CCS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.38, CCS is doing worse than 87.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.56
Quick Ratio 0.38
CCS Yearly Current Assets VS Current LiabilitesCCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

CCS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.58%.
Measured over the past years, CCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.96% on average per year.
Looking at the last year, CCS shows a small growth in Revenue. The Revenue has grown by 5.66% in the last year.
CCS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.64% yearly.
EPS 1Y (TTM)-18.58%
EPS 3Y-11.26%
EPS 5Y22.96%
EPS Q2Q%-56.32%
Revenue 1Y (TTM)5.66%
Revenue growth 3Y1.42%
Revenue growth 5Y11.64%
Sales Q2Q%-3.73%

3.2 Future

The Earnings Per Share is expected to decrease by -12.27% on average over the next years. This is quite bad
The Revenue is expected to decrease by -0.57% on average over the next years.
EPS Next Y-38.82%
EPS Next 2Y-12.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.85%
Revenue Next 2Y-0.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCS Yearly Revenue VS EstimatesCCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
CCS Yearly EPS VS EstimatesCCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.46, the valuation of CCS can be described as very cheap.
85.71% of the companies in the same industry are more expensive than CCS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CCS to the average of the S&P500 Index (27.03), we can say CCS is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.68, the valuation of CCS can be described as very cheap.
Based on the Price/Forward Earnings ratio, CCS is valued cheaper than 85.71% of the companies in the same industry.
CCS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.46
Fwd PE 7.68
CCS Price Earnings VS Forward Price EarningsCCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than CCS, based on the Enterprise Value to EBITDA ratio.
CCS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCS is cheaper than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.91
EV/EBITDA 7.28
CCS Per share dataCCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

CCS's earnings are expected to decrease with -12.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-12.27%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.06%, CCS has a reasonable but not impressive dividend return.
CCS's Dividend Yield is a higher than the industry average which is at 3.45.
Compared to an average S&P500 Dividend Yield of 2.40, CCS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.06%

5.2 History

CCS has been paying a dividend for over 5 years, so it has already some track record.
CCS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
CCS Yearly Dividends per shareCCS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

13.07% of the earnings are spent on dividend by CCS. This is a low number and sustainable payout ratio.
DP13.07%
EPS Next 2Y-12.27%
EPS Next 3YN/A
CCS Yearly Income VS Free CF VS DividendCCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
CCS Dividend Payout.CCS Dividend Payout, showing the Payout Ratio.CCS Dividend Payout.PayoutRetained Earnings

CENTURY COMMUNITIES INC

NYSE:CCS (8/6/2025, 12:24:35 PM)

61.49

+0.83 (+1.37%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners92.53%
Inst Owner Change-1.29%
Ins Owners12.63%
Ins Owner Change16.33%
Market Cap1.83B
Analysts73.33
Price Target70.38 (14.46%)
Short Float %7.21%
Short Ratio4.59
Dividend
Industry RankSector Rank
Dividend Yield 2.06%
Yearly Dividend1.04
Dividend Growth(5Y)N/A
DP13.07%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-28 2025-05-28 (0.29)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.59%
Min EPS beat(2)-23.59%
Max EPS beat(2)0.42%
EPS beat(4)2
Avg EPS beat(4)-5.85%
Min EPS beat(4)-23.59%
Max EPS beat(4)0.42%
EPS beat(8)6
Avg EPS beat(8)13.17%
EPS beat(12)10
Avg EPS beat(12)19.53%
EPS beat(16)14
Avg EPS beat(16)17.92%
Revenue beat(2)1
Avg Revenue beat(2)2.08%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)7.44%
Revenue beat(4)2
Avg Revenue beat(4)1.12%
Min Revenue beat(4)-3.28%
Max Revenue beat(4)7.44%
Revenue beat(8)5
Avg Revenue beat(8)8.65%
Revenue beat(12)9
Avg Revenue beat(12)10.61%
Revenue beat(16)11
Avg Revenue beat(16)7.72%
PT rev (1m)1.47%
PT rev (3m)-28.12%
EPS NQ rev (1m)-50.87%
EPS NQ rev (3m)-71.93%
EPS NY rev (1m)3.96%
EPS NY rev (3m)-33.68%
Revenue NQ rev (1m)-14.87%
Revenue NQ rev (3m)-32.57%
Revenue NY rev (1m)-3.03%
Revenue NY rev (3m)-16.17%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 7.68
P/S 0.42
P/FCF 13.91
P/OCF 11.66
P/B 0.71
P/tB 0.72
EV/EBITDA 7.28
EPS(TTM)8.24
EY13.4%
EPS(NY)8.01
Fwd EY13.02%
FCF(TTM)4.42
FCFY7.19%
OCF(TTM)5.27
OCFY8.58%
SpS145.36
BVpS86.39
TBVpS85
PEG (NY)N/A
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 5.68%
ROE 10.14%
ROCE 10.28%
ROIC 7.69%
ROICexc 7.87%
ROICexgc 9.44%
OM 9.89%
PM (TTM) 6.03%
GM 22.08%
FCFM 3.04%
ROA(3y)9.18%
ROA(5y)9.81%
ROE(3y)16.01%
ROE(5y)18.47%
ROIC(3y)11.48%
ROIC(5y)12.4%
ROICexc(3y)12.32%
ROICexc(5y)13.67%
ROICexgc(3y)14.46%
ROICexgc(5y)16.41%
ROCE(3y)15.8%
ROCE(5y)17.71%
ROICexcg growth 3Y-22.02%
ROICexcg growth 5Y8.94%
ROICexc growth 3Y-20.98%
ROICexc growth 5Y8.42%
OM growth 3Y-12.42%
OM growth 5Y9.7%
PM growth 3Y-13.74%
PM growth 5Y11.24%
GM growth 3Y-4.17%
GM growth 5Y4%
F-Score4
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 12.1
Debt/EBITDA 3.51
Cap/Depr 97.62%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 34.59%
Profit Quality 50.45%
Current Ratio 8.56
Quick Ratio 0.38
Altman-Z 3.29
F-Score4
WACC8.11%
ROIC/WACC0.95
Cap/Depr(3y)205.37%
Cap/Depr(5y)157.48%
Cap/Sales(3y)0.84%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.58%
EPS 3Y-11.26%
EPS 5Y22.96%
EPS Q2Q%-56.32%
EPS Next Y-38.82%
EPS Next 2Y-12.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.66%
Revenue growth 3Y1.42%
Revenue growth 5Y11.64%
Sales Q2Q%-3.73%
Revenue Next Year-8.85%
Revenue Next 2Y-0.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.36%
EBIT growth 3Y-11.18%
EBIT growth 5Y22.47%
EBIT Next Year-26.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.59%
OCF growth 3YN/A
OCF growth 5YN/A